Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/1999

01-07-1999 | Case Report

Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney

Authors: Dilek Dinçol, Ali Arican, Arzu Ensari, Serdar Akyar, Yaşar Bedük, Abdülkadir Cengiz

Published in: Medical Oncology | Issue 2/1999

Login to get access
Metadata
Title
Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney
Authors
Dilek Dinçol
Ali Arican
Arzu Ensari
Serdar Akyar
Yaşar Bedük
Abdülkadir Cengiz
Publication date
01-07-1999
Publisher
Humana Press
Published in
Medical Oncology / Issue 2/1999
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/BF02785847

Other articles of this Issue 2/1999

Medical Oncology 2/1999 Go to the issue

Original Paper

Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection?

Original Paper

Transforming growth factor-β and multidrug resistance in chronic lymphocytic leukemia

Review

Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM)

Original Paper

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis

Review

Cancer gene and immunotherapy: recent developments

Original Paper

Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits